Personal information

Other IDs

Loop profile: 1065106

Activities

Collapse all

Employment (2)

VIB-UGent Inflammation Reseach Center: Ghent, BE

2019-10-01 to present | PhD Student (Laboratory of Immunoregulation and Mucosal Immunology)
Employment
Source: Self-asserted source
Karel FA Van Damme

Ghent University: Ghent, BE

2017-10-01 to 2019-09-30 | Resident (Internal medicine)
Employment
Source: Self-asserted source
Karel FA Van Damme

Funding (2)

Linking the microbiome and the B cell repertoire to lupus nephritis

2022 to 2024 | Grant
Lupus Research Alliance (New York, New York, US)
Source: Self-asserted source
Karel FA Van Damme

PhD Fellowship Fundamental Research

2020-11 to 2024-10 | Grant
Fonds Wetenschappelijk Onderzoek (Brussels, BE)
Source: Self-asserted source
Karel FA Van Damme

Works (14)

Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice.

Scientific reports
2023-10-21 | Journal article
DOI: 10.1038/s41598-023-45324-8
PMID: 37865713
PMC: PMC10590390
Contributors: Van Damme KFA; Pieter Hertens; Martens A; Gilis E; Priem D; Bruggeman I; Fossoul A; Declercq J; Aegerter H; Andy Wullaert et al.
Source: Self-asserted source
Karel FA Van Damme

A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19

Science Translational Medicine
2023-08-23 | Journal article
DOI: 10.1126/scitranslmed.adi0252
Contributors: Karel F. A. Van Damme; Levi Hoste; Jozefien Declercq; Elisabeth De Leeuw; Bastiaan Maes; Liesbet Martens; Roos Colman; Robin Browaeys; Cédric Bosteels; Stijn Verwaerde et al.
Source: check_circle
Crossref

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19

2023-03-27 | Preprint
DOI: 10.1101/2023.03.25.23287712
Contributors: Karel F.A. Van Damme; Levi Hoste; Jozefien Declercq; Elisabeth De Leeuw; Bastiaan Maes; Liesbet Martens; Roos Colman; Robin Browaeys; Cédric Bosteels; Stijn Verwaerde et al.
Source: check_circle
Crossref

Immunosenescence: an unexplored role in glomerulonephritis.

Clinical & translational immunology
2022-11-20 | Journal article
DOI: 10.1002/cti2.1427
PMID: 36420421
PMC: PMC9676375
Contributors: Steven Van Laecke; Van Damme K; Amélie Dendooven
Source: Self-asserted source
Karel FA Van Damme

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment.

Cell reports. Medicine
2022-11-15 | Journal article
DOI: 10.1016/j.xcrm.2022.100833
PMID: 36459994
PMC: PMC9663750
Contributors: Bosteels C; Van Damme KFA; De Leeuw E; Declercq J; Maes B; Bosteels V; Hoste L; Naesens L; Debeuf N; Deckers J et al.
Source: Self-asserted source
Karel FA Van Damme

Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial.

Respiratory research
2022-08-09 | Journal article
DOI: 10.1186/s12931-022-02126-2
PMID: 35945604
PMC: PMC9361275
Contributors: De Leeuw E; Van Damme KFA; Declercq J; Bosteels C; Maes B; Tavernier SJ; Detalle L; Smart T; Glatt S; Debeuf N et al.
Source: Self-asserted source
Karel FA Van Damme

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial

The Lancet Respiratory Medicine
2021-12 | Journal article
DOI: 10.1016/s2213-2600(21)00377-5
Part of ISSN: 2213-2600
Contributors: Jozefien Declercq; Karel F A Van Damme; Elisabeth De Leeuw; Bastiaan Maes; Cedric Bosteels; Simon J Tavernier; Stefanie De Buyser; Roos Colman; Maya Hites; Gil Verschelden et al.
Source: Self-asserted source
Karel FA Van Damme

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.

The Journal of experimental medicine
2021-12-16 | Journal article | Author
DOI: 10.1084/jem.20211381
PMID: 34914824
PMC: PMC8685281
Contributors: Levi Hoste; Lisa Roels; Leslie Naesens; Victor Bosteels; Stijn Vanhee; Sam Dupont; Cedric Bosteels; Robin Browaeys; Niels Vandamme; Kevin Verstaen et al.
Source: Self-asserted source
Karel FA Van Damme

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis.

JAMA
2021-08-01 | Journal article
DOI: 10.1001/jama.2021.11330
PMID: 34228774
PMC: PMC8261689
Contributors: WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M; Claire Vale; Peter J Godolphin; David Fisher; Higgins JPT; Francesca Spiga; Jelena Savović; Jayne F Tierney; Baron G et al.
Source: Self-asserted source
Karel FA Van Damme

Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial

Trials
2020-12 | Journal article
DOI: 10.1186/s13063-020-04451-7
Part of ISSN: 1745-6215
Source: Self-asserted source
Karel FA Van Damme

Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial

Trials
2020-12 | Journal article
DOI: 10.1186/s13063-020-04453-5
Part of ISSN: 1745-6215
Source: Self-asserted source
Karel FA Van Damme

Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19

Frontiers in Immunology
2020-11-20 | Journal article
DOI: 10.3389/fimmu.2020.596761
Source: Self-asserted source
Karel FA Van Damme

Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial

Trials
2020-11-19 | Journal article
DOI: 10.1186/s13063-020-04884-0
Source: Self-asserted source
Karel FA Van Damme

Bone scan findings in calcific tendinitis at the gluteus maximus insertion: some illustrative cases

Radiology Case Reports
2017-03 | Journal article
DOI: 10.1016/j.radcr.2016.11.009
Part of ISSN: 1930-0433
Contributors: Karel Van Damme; Liesbeth De Coster; Koen Mermuys; Anja Van den Eeckhaut; Natascha Walgraeve; Frank De Geeter
Source: Self-asserted source
Karel FA Van Damme via Crossref Metadata Search
How many people are using ORCID?